UTERINE RHABDOMYOSARCOMA
Uterine rhabdomyosarcomas are very rare. They are characterized by late diagnosis and poor prognosis. In this paper we report clinical manifestations of this tumor in a 37-year-old patient. Rhabdomyosarcomas are treated similarly to endometrial sarcomas. The initial therapy for most uterine sarcomas...
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | Brasil |
| Institución: | Universidade Federal do Rio Grande do Sul (UFRGS) |
| Repositorio: | Clinical and Biomedical Research |
| Idioma: | portugués |
| OAI Identifier: | oai:seer.ufrgs.br:article/126144 |
| Acceso en línea: | https://seer.ufrgs.br/index.php/hcpa/article/view/126144 |
| Access Level: | acceso abierto |
| Palabra clave: | Rabdomiossarcoma sarcoma uterino câncer sangramento uterino Rhabdomyosarcoma uterine sarcoma cancer uterine bleeding |
| Sumario: | Uterine rhabdomyosarcomas are very rare. They are characterized by late diagnosis and poor prognosis. In this paper we report clinical manifestations of this tumor in a 37-year-old patient. Rhabdomyosarcomas are treated similarly to endometrial sarcomas. The initial therapy for most uterine sarcomas is exploratory laparotomy, total abdominal hysterectomy, and bilateral salpingo-oophorectomy. There is not much information about the epidemiologic risk factors for sarcoma; similarly, little work has been performed assessing molecular alterations in sarcomas. Because of their rarity, uterine sarcomas are not suitable for screening. They are best managed by specialists with expertise in these malignancies, but primary care physicians can play an important role in the early diagnosis. In suspected cases, endometrial biopsy or dilation and curettage may aid diagnosis. |
|---|